General Notices

• NHLBI Announces Availability of Frequently Asked Questions (FAQs) for RFA-HL-20-006 Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Independent Clinical Trial Not Allowed)
  (NOT-HL-21-013)
  National Heart, Lung, and Blood Institute
  National Cancer Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  

• Availability of Frequently Asked Questions (FAQs) for RFA-HL-22-007 and RFA-HL-22-008: Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) program
  (NOT-HL-21-014)
  National Heart, Lung, and Blood Institute
  

• Notice to Extend the Response Date for NOT-LM-21-005, "Request for Information (RFI): Use of Common Data Elements (CDEs) in NIH-funded Research"
  (NOT-LM-21-008)
  National Library of Medicine
  

• Notice of Correction to Award Budget for PA-21-235, "NIMH Exploratory/Developmental Research Grant (R21 Clinical Trial Not Allowed)"
  (NOT-MH-21-290)
  National Institute of Mental Health
  

• Request for Information (RFI): Seeking Stakeholder Input on Enhancing Diversity and Inclusion in the Cancer Research Workforce
  (NOT-CA-21-067)
  National Cancer Institute
  

• Request for Information (RFI): Facilitating the Early Diagnosis and Equitable Delivery of Gene-Targeted Therapies to Individuals with Rare Diseases
  (NOT-TR-21-027)
  National Center for Advancing Translational Sciences
  

Notice of Changes to Funding Opportunities

• Notice of Change to Eligibility Information for RFA-AA-20-013 "Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia (U01 Clinical Trial Optional)
  (NOT-AA-21-030)
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice of NIAAA's participation in NOT-NS-21-049, "Notice of Special Interest (NOSI): NIH Research Project Grant (R01) Applications from Individuals from Diverse Backgrounds, Including Under-Represented Minorities"
  (NOT-AA-21-031)
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice of NIDCD Withdrawal from Participation in PA-20-184, "Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)
  (NOT-DC-21-002)
  National Institute on Deafness and Other Communication Disorders
  

• Notice of Correction to the Application and Submission Instructions for the Pilot and Feasibility Program for RFA-DK-21-015, Nutrition Obesity Research Centers (P30 Clinical Trial Optional)
  (NOT-DK-21-020)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

• Notice of Termination of NIEHS Participation on NOT-EB-21-012, Notice of Extension of the Expiration Date of PAR-19-159, "Bioengineering Research Grants (BRG) (R01 Clinical Trial Required)"
  (NOT-ES-21-007)
  National Institute of Environmental Health Sciences
  

• Notice of Correction to NOT-OD-21-103, "Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations RADx-UP Phase II (Emergency Supplement - Clinical Trial Optional)
  (NOT-OD-21-125)
  National Institutes of Health
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54 Clinical Trial Not Allowed)
  (NOT-CA-21-079)
  National Cancer Institute
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Data and Resource Coordination Center (DRCC) (U24 Clinical Trial Not Allowed)
  (NOT-CA-21-080)
  National Cancer Institute
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint Medtech: Small Business Translator (U44)
  (NOT-DA-22-050)
  National Institute on Drug Abuse
  National Center for Complementary and Integrative Health
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Office of Behavioral and Social Sciences Research
  

• RESCINDED - Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint MedTech: Prototype Developer (U18 Clinical Trial Not Allowed)
  (NOT-EB-21-018)
  National Institute of Biomedical Imaging and Bioengineering
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Office of Behavioral and Social Sciences Research
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint MedTech: Incubator Hubs (U54 Clinical Trial Not Allowed)
  (NOT-EB-21-019)
  National Institute of Biomedical Imaging and Bioengineering
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Office of Behavioral and Social Sciences Research
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint MedTech: Translator (UG3/UH3 Clinical Trial Optional)
  (NOT-NS-21-057)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  Office of Behavioral and Social Sciences Research
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Availability of Urgent Award for Competitive Revisions to IDeA-CTR Awards to Address the Continued Need for Documenting COVID-19-Related Patient Outcomes
  (NOT-GM-21-050)
  National Institute of General Medical Sciences
  

• Notice of Special Interest (NOSI): Administrative Supplements to Enhance Data Science Capacity at NIMHD-Funded Research Centers in Minority Institutions (RCMI)
  (NOT-MD-21-021)
  National Institute on Minority Health and Health Disparities
  Office of the Director, NIH
  Office of Research on Women's Health
  

Funding Opportunities

• Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 - Clinical Trial Optional)
  (PA-21-180)
  National Institute on Drug Abuse
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Development and Testing of Novel Interventions to improve HIV Prevention, Treatment, and Program Implementation for People Who Use Drugs (R34 Clinical Trial Required)
  (PA-21-205)
  National Institute on Drug Abuse
  Application Receipt Date(s): Not Applicable
  
  

• Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Optional)
  (PA-21-219)
  National Institute of Neurological Disorders and Stroke
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• NIMH Exploratory/Developmental Research Grant (R21 Clinical Trial Not Allowed)
  (PA-21-235)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Summer Research Education Experience Program (R25 Clinical Trial Not Allowed)
  (PAR-21-168)
  National Institute of Neurological Disorders and Stroke
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): March 17, 2022, March 17, 2023, and March 19, 2024
  
  

• Emerging Science and Technology in Transplantation (U01 Clinical Trial Not Allowed)
  (RFA-AI-21-016)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): September 03, 2021
  
  

• SBIR E-Learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed)
  (RFA-ES-21-005)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): July 30, 2021
  
  

• T32 Training Program for Institutions That Promote Diversity (T32 Clinical Trial Not Allowed)
  (RFA-HL-22-001)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): Multiple dates, see announcement.